LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 28.21 | 84.90 | 648 | 2091 | 0.3098 | 0.5522 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 28.21 | 84.90 | 842 | 2091 | 0.4026 | 0.6427 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 28.21 | 84.90 | 515 | 2091 | 0.2462 | 0.4769 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 28.21 | 84.90 | 854 | 2091 | 0.4083 | 0.6477 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 29.92 | 84.90 | 660 | 2237 | 0.2949 | 0.5442 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 29.92 | 84.90 | 860 | 2237 | 0.3843 | 0.6332 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 29.92 | 84.90 | 519 | 2237 | 0.2319 | 0.4675 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 29.92 | 84.90 | 855 | 2237 | 0.3821 | 0.6312 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 31.62 | 84.90 | 668 | 2449 | 0.2727 | 0.5300 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 31.62 | 84.90 | 858 | 2449 | 0.3502 | 0.6110 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 31.62 | 84.90 | 550 | 2449 | 0.2245 | 0.4699 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 31.62 | 84.90 | 851 | 2449 | 0.3474 | 0.6083 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 33.32 | 84.90 | 662 | 2722 | 0.2432 | 0.5076 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 33.32 | 84.90 | 852 | 2722 | 0.3130 | 0.5856 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 33.32 | 84.90 | 567 | 2722 | 0.2083 | 0.4616 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 33.32 | 84.90 | 866 | 2722 | 0.3181 | 0.5908 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 35.03 | 84.90 | 616 | 2991 | 0.2059 | 0.4706 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 35.03 | 84.90 | 836 | 2991 | 0.2795 | 0.5606 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 35.03 | 84.90 | 553 | 2991 | 0.1849 | 0.4400 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 35.03 | 84.90 | 849 | 2991 | 0.2838 | 0.5653 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 36.73 | 84.90 | 621 | 3254 | 0.1908 | 0.4598 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 36.73 | 84.90 | 852 | 3254 | 0.2618 | 0.5502 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 36.73 | 84.90 | 508 | 3254 | 0.1561 | 0.4051 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 36.73 | 84.90 | 853 | 3254 | 0.2621 | 0.5506 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 38.43 | 84.90 | 628 | 3459 | 0.1815 | 0.4537 | MN20160318_Q02 | F05 |